MAPK/ERK


The mitogen-activated protein kinase (MAPK) is a highly conserved family of serine/threonine kinases that mediate a board range of cellular processes, including proliferation, differentiation, motility, migration, stress response, apoptosis and survival. The activation of MAPK involves signaling pathways consisting of MAPK kinase (i.e. MAPKKK or MEKK) that activates MAPK/ERK (i.e. MAPKK or MEK). A variety of extracellular signals such as mitogens, cytokines, growth factors, and environmental stressors stimulate a phosphorylation-dependent increase in the activity of MAPK.
Activated MAPKs transduce the phosphorylation and activation of MAPK-activated protein kinases (MAPKAPKs), e.g. RSK, MSK, or MNK family, and MK2/3/5. There are three main MAPK families, signal-regulated kinase 1 and 2 (Erk1/2 or p44/42), the c-Jun N-terminal kinases 1-3 (JNK1-3)/ stress activated protein kinases (SAPK1A, 1B, 1C), the p38 isoforms (p38α, β, γ, and δ). ERK signaling is involved in cell division, migration and survival. p38 MAPK and JNK/SAPK pathways are activated by cellular stress. The p38 MAPK pathway regulates cell motility, transcription, and chromatin remodeling. JNK/SAPK signaling affects apoptosis and inflammation. Dysregulation of MAPK pathway results in tumorgenesis and other pathological conditions.
-
C9004 Cephradine monohydrateSummary: Cephradine monohydrate is a first-generation cephalosporin β-lactam compound that inhibits bacterial cell wall synthesis and is utilized in microbiology and antibiotic resistance research. -
N2913 CitroptenSummary: Citropten is a naturally occurring coumarin derivative that modulates oxidative stress and inflammatory signaling pathways, widely utilized in pharmacology and natural products research. -
N2895 IsoquercitrinSummary: A natural polyphenolic flavonoid inhibitor of the Wnt/β-catenin pathway. -
C4675 AcenocoumarolSummary: A potent vitamin K epoxide reductase (VKOR) inhibitor and vitamin K antagonist. -
C9064 PlixorafenibSummary: A selective BRAF inhibitor for research use, suitable for in vitro studies of the MAPK pathway. -
C9074 Lidocaine HClSummary: An amide-type voltage-gated sodium channel blocking research probe for in vitro electrophysiology and mechanistic evaluation. -
C9080 LY2584702 TosylateSummary: An ATP-competitive, selective p70S6K kinase inhibitor, for research use only. -
C9081 BI-3406Summary: A KRASSOS1 inhibitor for RAS pathway research, with nanomolar in vitro activity. -
C9099 OTS514 HClSummary: A selective PBK/TOPK inhibitor for in vitro kinase and tumor pathway research. -
C9106 AZD0364Summary: A highly selective ERK1/2 inhibitory chemical probe suitable for mechanistic studies of the MAPK pathway.
